BRIEF-Depomed to buy U.S. rights to Nucynta from Janssen for $1.05 bln
January 15, 2015 at 16:52 PM EST
* Entered into agreement to acquire u.s. Rights to Nucynta franchise from Janssen Pharma for $1.05 billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.